We are live on ! Find out more
DY

Dowling & Yahnke Portfolio holdings

AUM $2.15B
1-Year Est. Return 10.82%
This Fund
S&P 500
This Quarter Est. Return
+6.39%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
AUM
$1.11B
AUM Growth
+$121M
Cap. Flow
+$60.5M
Cap. Flow %
5.47%
Top 10 Hldgs %
22.97%
Holding
307
New
21
Increased
95
Reduced
149
Closed
16

Sector Composition

Rank Sector Weight
1 Miscellaneous 24.68%
2 Healthcare 12.86%
3 Financials 12.1%
4 Technology 12.09%
5 Consumer Staples 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INTU icon
126
Intuit
INTU
$97.9B
$2.38M 0.21%
15,067
+477
+3% +$72.7K
BNDX icon
127
Vanguard Total International Bond ETF
BNDX
$82.5B
$2.38M 0.21%
+43,702
New +$2.4M
GD icon
128
General Dynamics
GD
$103B
$2.33M 0.21%
11,478
-142
-1% -$29K
BIIB icon
129
Biogen
BIIB
$32.3B
$2.33M 0.21%
7,315
+133
+2% +$42.7K
VEA icon
130
Vanguard FTSE Developed Markets ETF
VEA
$238B
$2.25M 0.2%
50,226
-4,209
-8% -$186K
VSS icon
131
Vanguard FTSE All-World ex-US Small-Cap Index Fund
VSS
$12.1B
$2.24M 0.2%
18,814
-396
-2% -$46.1K
STT icon
132
State Street
STT
$53.1B
$2.24M 0.2%
22,968
+135
+0.6% +$12.9K
GIS icon
133
General Mills
GIS
$22.2B
$2.23M 0.2%
37,690
-4,373
-10% -$237K
OXY icon
134
Occidental Petroleum
OXY
$59.1B
$2.23M 0.2%
30,264
+1,235
+4% +$83.8K
BKNG icon
135
Booking.com
BKNG
$155B
$2.15M 0.19%
30,900
+625
+2% +$45.3K
VHT icon
136
Vanguard Health Care ETF
VHT
$19.3B
$2.15M 0.19%
13,923
-200
-1% -$30.7K
TMO icon
137
Thermo Fisher Scientific
TMO
$230B
$2.13M 0.19%
11,240
+314
+3% +$60.2K
AFL icon
138
Aflac
AFL
$58.4B
$2.12M 0.19%
48,330
-2,224
-4% -$94.9K
VCR icon
139
Vanguard Consumer Discretionary ETF
VCR
$6.04B
$2.12M 0.19%
13,576
+495
+4% +$73.8K
AIG icon
140
American International
AIG
$40.2B
$2.1M 0.19%
35,290
-2,866
-8% -$176K
IDU icon
141
iShares US Utilities ETF
IDU
$1.31B
$2.1M 0.19%
31,538
-150
-0.5% -$10.3K
MDT icon
142
Medtronic
MDT
$117B
$2.04M 0.18%
25,280
-1,036
-4% -$83K
VNQ icon
143
Vanguard Real Estate ETF
VNQ
$38.6B
$2M 0.18%
+24,039
New +$2.01M
EMB icon
144
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$1.99M 0.18%
+17,165
New +$1.99M
TFCFA
145
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$1.98M 0.18%
57,372
-2,285
-4% -$68.2K
XES icon
146
State Street SPDR S&P Oil & Gas Equipment & Services ETF
XES
$385M
$1.95M 0.18%
11,387
+801
+8% +$127K
VTI icon
147
Vanguard Morningstar Total Stock Market ETF
VTI
$687B
$1.94M 0.18%
14,143
-62
-0.4% -$8.3K
VZ icon
148
Verizon
VZ
$208B
$1.92M 0.17%
36,323
+2,670
+8% +$131K
SCZ icon
149
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.3B
$1.87M 0.17%
29,018
SYK icon
150
Stryker
SYK
$127B
$1.87M 0.17%
12,069
+108
+0.9% +$16.5K

Similar funds

Dowling & Yahnke's Q4 2017 Portfolio in Review

As of Q4 2017, Dowling & Yahnke held 307 positions worth $1.11B, up 12% from $985M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Dowling & Yahnke deployed $60.5M of net new capital in Q4 2017, opening 21 new positions and adding to 95 existing holdings. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 479,412 shares worth $38.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was GE Aerospace, an estimated $1.53M trimmed.

  • Dowling & Yahnke's largest Q4 2017 buy was Vanguard Emerging Markets Government Bond ETF: 479,412 shares worth $38.5M.
  • Dowling & Yahnke added most to DexCom in Q4 2017, an estimated $1.82M increase.
  • Dowling & Yahnke's biggest Q4 2017 reduction was GE Aerospace, cutting an estimated $1.53M.
  • Dowling & Yahnke fully exited Allergan Inc in Q4 2017, selling an estimated $428K.
  • Dowling & Yahnke's ten largest holdings make up 23% of its $1.11B portfolio in Q4 2017.
  • Dowling & Yahnke opened 21 new positions and closed 16 in Q4 2017.
  • Dowling & Yahnke's portfolio value rose 12% quarter-over-quarter to $1.11B.

Based on Dowling & Yahnke's 13F filing for Q4 2017, filed 2 Feb 2018.